Literature DB >> 24256377

Identification and control of a poliomyelitis outbreak in Xinjiang, China.

Hui-Ming Luo1, Yong Zhang, Xin-Qi Wang, Wen-Zhou Yu, Ning Wen, Dong-Mei Yan, Hua-Qing Wang, Fuerhati Wushouer, Hai-Bo Wang, Ai-Qiang Xu, Jing-Shan Zheng, De-Xin Li, Hui Cui, Jian-Ping Wang, Shuang-Li Zhu, Zi-Jian Feng, Fu-Qiang Cui, Jing Ning, Li-Xin Hao, Chun-Xiang Fan, Gui-Jun Ning, Hong-Jie Yu, Shi-Wen Wang, Da-Wei Liu, Dong-Yan Wang, Jian-Ping Fu, Ai-li Gou, Guo-Min Zhang, Guo-Hong Huang, Yuan-Sheng Chen, Sha-Sha Mi, Yan-Min Liu, Da-Peng Yin, Hui Zhu, Xin-Chun Fan, Xin-Lan Li, Yi-Xin Ji, Ke-Li Li, Hai-Shu Tang, Wen-Bo Xu, Yu Wang, Wei-Zhong Yang.   

Abstract

BACKGROUND: The last case of infection with wild-type poliovirus indigenous to China was reported in 1994, and China was certified as a poliomyelitis-free region in 2000. In 2011, an outbreak of infection with imported wild-type poliovirus occurred in the province of Xinjiang.
METHODS: We conducted an investigation to guide the response to the outbreak, performed sequence analysis of the poliovirus type 1 capsid protein VP1 to determine the source, and carried out serologic and coverage surveys to assess the risk of viral propagation. Surveillance for acute flaccid paralysis was intensified to enhance case ascertainment.
RESULTS: Between July 3 and October 9, 2011, investigators identified 21 cases of infection with wild-type poliovirus and 23 clinically compatible cases in southern Xinjiang. Wild-type poliovirus type 1 was isolated from 14 of 673 contacts of patients with acute flaccid paralysis (2.1%) and from 13 of 491 healthy persons who were not in contact with affected persons (2.6%). Sequence analysis implicated an imported wild-type poliovirus that originated in Pakistan as the cause of the outbreak. A public health emergency was declared in Xinjiang after the outbreak was confirmed. Surveillance for acute flaccid paralysis was enhanced, with daily reporting from all public and private hospitals. Five rounds of vaccination with live, attenuated oral poliovirus vaccine (OPV) were conducted among children and adults, and 43 million doses of OPV were administered. Trivalent OPV was used in three rounds, and monovalent OPV type 1 was used in two rounds. The outbreak was stopped 1.5 months after laboratory confirmation of the index case.
CONCLUSIONS: The 2011 outbreak in China showed that poliomyelitis-free countries remain at risk for outbreaks while the poliovirus circulates anywhere in the world. Global eradication of poliomyelitis will benefit all countries, even those that are currently free of poliomyelitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256377     DOI: 10.1056/NEJMoa1303368

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

1.  Poliomyelitis: historical facts, epidemiology, and current challenges in eradication.

Authors:  Man Mohan Mehndiratta; Prachi Mehndiratta; Renuka Pande
Journal:  Neurohospitalist       Date:  2014-10

2.  Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.

Authors:  Dongmei Yan; Yong Zhang; Shuangli Zhu; Na Chen; Xiaolei Li; Dongyan Wang; Xiaozhen Ma; Hui Zhu; Wenbin Tong; Wenbo Xu
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

3.  Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011.

Authors:  Nicksy Gumede; Jaume Jorba; Jagadish Deshpande; Mark Pallansch; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Olen Kew; Marietjie Venter; Cara C Burns
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

4.  Perspective: Elimination round.

Authors:  Andrew W Artenstein; Gregory A Poland
Journal:  Nature       Date:  2014-03-06       Impact factor: 49.962

5.  Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.

Authors:  Juan Li; Zhujiazi Zhang; Herun Zhang; Maozhong Li; Xiaomei Li; Li Lu; Fang Huang; Jiang Wu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

6.  Household survey analysis of the impact of comprehensive strategies to improve the expanded programme on immunisation at the county level in western China, 2006-2010.

Authors:  Yuqing Zhou; Yi Xing; Xiaofeng Liang; Chenyan Yue; Xu Zhu; David Hipgrave
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

7.  Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.

Authors:  Jan Felix Drexler; Gilda Grard; Alexander N Lukashev; Liubov I Kozlovskaya; Sindy Böttcher; Gökhan Uslu; Johan Reimerink; Anatoly P Gmyl; Raphaël Taty-Taty; Sonia Etenna Lekana-Douki; Dieudonné Nkoghe; Anna M Eis-Hübinger; Sabine Diedrich; Marion Koopmans; Eric M Leroy; Christian Drosten
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

8.  The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.

Authors:  Qunying Mao; Yiping Wang; Jie Shao; Zhifang Ying; Fan Gao; Xin Yao; Changgui Li; Qiang Ye; Miao Xu; Rongcheng Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015-02-25       Impact factor: 3.452

9.  The association between the density of vaccination workers and immunization coverage in Zhejiang province, East China.

Authors:  Yu Hu; Yaping Chen; Ying Wang; Hu Liang; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452

Review 10.  Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Authors:  Steven G F Wassilak; M Steven Oberste; Rudolph H Tangermann; Ousmane M Diop; Hamid S Jafari; Gregory L Armstrong
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.